Tuesday, February 17, 2009
Uloric (Febuxostat) approved by the FDA for gout
Uloric (TMX-67 or febuxostat) was approved by the FDA for the treatment of gout. It's been over 40 years since the FDA has approved a new drug specifically for gout. Febuxostat is a highly potent non-purine selective inhibitor of xanthine oxidasewas and it was approved by the European Union (EU) last year, and now we have the FDA approval this year. We're always lagging behind the EU - I wonder if we'll ever catch up. Uloric is made by Takeda Pharmaceutical Company Limited.